Indian Institute of Chemical Biology

EPrints@IICB Welcomes! - EPrints@IICB
Not a member yet
    2058 research outputs found

    MECHANISM OF miRNA ACTIVITY REGULATION IN MAMMALIAN CELLS

    No full text
    Cells must be able to respond to changes in their microenvironment in order to survive. Genes encode proteins and proteins dictate cell function. Information flows from DNA to RNA to protein, according to the central dogma of molecular biology and each of the steps are under stringent regulatory control to ensure cell fate and function. Cells can control which genes get transcribed and which transcripts get translated. Regulation of the two major steps — transcription and translation — is critical to its adaptability. Regulation of transcription and translation occurs in both prokaryotes and eukaryotes, but it is far more complex in eukaryotes. MicroRNAs (miRNAs) are a class of small non-coding RNAs that posttranscriptionally regulate gene expression via translational repression and/or mRNA degradation. These tiny regulators search for cognate targets by base pairing with the 3’UTR of the target mRNAs. Over the years, since its discovery the role of miRNAs has become apparent in regulating developmental timing, host-pathogen interactions as well as cell differentiation, proliferation, apoptosis, tumorigenesis, etc. Just like any other regulatory element, the biogenesis, activity and turnover of miRNAs themselves are under strict regulatory control. Extensive research has established how miRNAs regulate target mRNAs by translation repression. However, information regarding the effect of target mRNA on biogenesis and stability of corresponding miRNAs is limited. In this study, we have reported increased biogenesis of cognate miRNAs in presence of abundant amounts of target mRNA in both cells as well as cell-free in vitro system. These miRNAs get loaded onto AGO2 to form functionally competent miRISCs. This target-driven miRNA increase is proportional to the concentration of target mRNA and is affected by the translatability of the target message. While investigating the molecular mechanism of the phenomenon, we identified that increased pre-miRNA processing by AGO2-associated DICER1 in presence of target mRNA, contributes to this increased miRNP formation. Compartmentalization of biological processes provides a mechanism of regulation of the processes with exquisite spatial and temporal control. We have observed that miRNA activity is compartmentalized on the rough Endoplasmic Reticulum (rER) membranes in human cells and have explored the effects of this compartmentalization on miRNA function. Probing further into the phenomenon of target driven miRNA biogenesis, we identified the rER membranes as the site of target mRNA-governed miRNA assembly in human cells. It is likely that target driven miRNA biogenesis operates in addition to the conventional process of repression by preformed miRNPs. Rather than transcriptionally upregulating miRNA synthesis, modulating the final step of biogenesis will serve as an immediate means to increase miRNA production. This in turn will help the cell respond to specific and urgent cellular needs like rapid target driven miR-122 biogenesis during starvation stress reversal in human hepatic cells. Thus, we have identified an additional layer of post-transcriptional regulation of gene expression that helps the cell to maintain requisite levels of mature forms of respective miRNAs by modulating its synthesis depending on target availability

    Non-invasive management of visceral leishmaniasis: design, development and evaluation of clinically applicable immunodiagnostic tool for field settings

    No full text
    Diagnosis is a process of identifying a particular disease through signs and symptoms of a person. Clinical history of a person and physical examination may draw a conclusion that describes the reason for particular health problem. The literal meaning of diagnosis is “to distinguish” in Greek. Thus diagnosis is an act to discriminate or distinguish certain conditions (diseases) from others (healthy or other diseases). Medical diagnosis is most of the time very challenging because symptoms like fever, pain, weakness, etc. are common in many diseases mainly in infectious diseases. Therefore, pieces of information are collected and compared such as sign and symptoms of a person, endemic diseases in that area, season of the disease, etc. The first evidence of disease diagnosis is found in the treatise “Edwin Smith Papyrus” written by Imhotep, a polymath of ancient Egypt (27th century BC) (Figure 1.1). Babylonian scholar Esagil-kin-apli (11th Century BC) first introduced the reason, logic and symptoms for a disease in his diagnostic handbook “Sakikku” (Horstmanshoff, 2004). Hippocrates (460-370 BC), a famous Greek physician used biological samples such as urine, sweat, etc for diagnosis

    Endless Possibilities Around Indole: Asymmetric Synthesis, Atropisomerism, Potential Applications to Medicinal Chemistry and Materials Science

    No full text
    This thesis has embodied potential applications of an important heterocycle indole in the field of asymmetric synthesis, axial chirality, biology, and study of their chiroptical properties. A brief updated review as chapter I covers all the recent aspects on the emerging values of indoles in the above mentioned research works

    Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies

    Full text link
    Garcinol (GAR) is a naturally occurring polyisoprenylated phenolic compound. It has been recently investigated for its biological activities such as antioxidant, anti-inflammatory, anti ulcer, and antiproliferative effect on a wide range of human cancer cell lines. Though the outcomes are very promising, its extreme insolubility in water remains the main obstacle for its clinical application. Herein we report the formulation of GAR entrapped PLGA nanoparticles by nanoprecipitation method using vitamin E TPGS as an emulsifier. The nanoparticles were characterized for size, surface morphology, surface charge, encapsulation efficiency and in vitro drug release kinetics. The MTT assay depicted a high amount of cytotoxicity of GAR-NPs in B16F10, HepG2 and KB cells. A considerable amount of cell apoptosis was observed in B16f10 and KB cell lines. In vivo cellular uptake of fluorescent NPs on B16F10 cells was also investigated. Finally the GAR loaded NPs were radiolabeled with technetium-99m with >95% labeling efficiency and administered to B16F10 melanoma tumor bearing mice to investigate the in vivo deposition at the tumor site by biodistribution and scintigraphic imaging study. In vitro cellular uptake studies and biological evaluation confirm the efficacy of the formulation for cancer treatmen

    A novel nanohybrid for cancer theranostics: folate sensitized Fe2O3 nanoparticles for colorectal cancer diagnosis and photodynamic therapy

    No full text
    Organic–inorganic nanohybrids are becoming popular for their potential biological applications, including diagnosis and treatment of cancerous cells. The motive of this study is to synthesise a nanohybrid for the diagnosis and therapy of colorectal cancer. Here we have developed a facile and cost-effective synthesis of folic acid (FA) templated Fe2O3 nanoparticles with excellent colloidal stability in water using a hydrothermal method for the theranostics applications. The attachment of FA to Fe2O3 was confirmed using various spectroscopic techniques including FTIR and picosecond resolved fluorescence studies. The nanohybrid (FA–Fe2O3) is a combination of two nontoxic ingredients FA and Fe2O3, showing remarkable photodynamic therapeutic (PDT) activity in human colorectal carcinoma cell lines (HCT 116) via generation of intracellular ROS. The light induced enhanced ROS activity of the nanohybrid causes significant nuclear DNA damage, as confirmed from the comet assay. Assessment of p53, Bax, Bcl2, cytochrome c (cyt c) protein expression and caspase 9/3 activity provides vivid evidence for cell death via an apoptotic pathway. In vitro magnetic resonance imaging (MRI) experiments in folate receptor (FR) overexpressed cancer cells (HCT 116) and FR deficient human embryonic kidney cells (HEK 293) reveal the target specificity of the nanohybrid towards cancer cells, and are thus pronounced MRI contrasting agents for the diagnosis of colorectal cance

    Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells

    No full text
    Extravasation and metastatic progression are two main reasons for the high mortality rate associated with cancer. The metastatic potential of cancer cells depends on a plethora of metabolic challenges prevailing within the tumor microenvironment. To achieve higher rates of proliferation, cancer cells reprogram their metabolism, increasing glycolysis and biosynthetic activities. Just why this metabolic reprogramming predisposes cells towards increased oncogenesis remains elusive. The accumulation of myriad oncolipids in the tumor microenvironment has been shown to promote the invasiveness of cancer cells, with lysophosphatidic acid (LPA) being one such critical factor enriched in ovarian cancer patients. Cellular bioenergetic studies confirm that oxidative phosphorylation is suppressed and glycolysis is increased with long exposure to LPA in ovarian cancer cells compared with non-transformed epithelial cells. We sought to uncover the regulatory complexity underlying this oncolipidinduced metabolic perturbation. Gene regulatory networking using RNASeq analysis identified the oncogene ETS-1 as a critical mediator of LPA-induced metabolic alterations for the maintenance of invasive phenotype. Moreover, LPA receptor-2 specific PtdIns3K-AKT signaling induces ETS-1 and its target matrix metalloproteases. Abrogation of ETS-1 restores cellular bioenergetics towards increased oxidative phosphorylation and reduced glycolysis, and this effect was reversed by the presence of LPA. Furthermore, the bioenergetic status of LPA-treated ovarian cancer cells mimics hypoxia through induction of hypoxia-inducible factor-1a, which was found to transactivate ets-1. Studies in primary tumors generated in syngeneic mice corroborated the in vitro findings. Thus, our study highlights the phenotypic changes induced by the prometastatic factor ETS-1 in ovarian cancer cells. The relationship between enhanced invasiveness and metabolic plasticity further illustrates the critical role of metabolic adaptation of cancer cells as a driver of tumor progression. These findings reveal oncolipid-induced metabolic predispositio

    Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis

    Full text link
    Earlier we have established a carbazole alkaloid (mahanine) isolated from an Indian edible medicinal plant as an anticancer agent with minimal effect on normal cells. Here we report for the first time that mahanine-treated drug resistant and sensitive virulent Leishmania donovani promastigotes underwent apoptosis through phosphatidylserine externalization, DNA fragmentation and cell cycle arrest. An early induction of reactive oxygen species (ROS) suggests that the mahanine-induced apoptosis was mediated by oxidative stress. Additionally, mahanine-treated Leishmania-infected macrophages exhibited anti-amastigote activity by nitric oxide (NO)/ROS generation along with suppression of uncoupling protein 2 and Th1-biased cytokines response through modulating STAT pathway. Moreover, we have demonstrated the interaction of a few antioxidant enzymes present in parasite with mahanine through molecular modeling. Reduced genetic and protein level expression of one such enzyme namely ascorbate peroxidase was also observed in mahanine-treated promastigotes. Furthermore, oral administration of mahanine in acute murine model exhibited almost complete reduction of parasite burden, upregulation of NO/iNOS/ROS/IL-12 and T cell proliferation. Taken together, we have established a new function of mahanine as a potent antileishmanial molecule, capable of inducing ROS and exploit antioxidant enzymes in parasite along with modulation of host’s immune response which could be developed as an inexpensive and nontoxic therapeutics either alone or in combination

    Small molecule induced poly(A) single strand to self-structure conformational switching: evidence for the prominent role of H-bonding interactions

    No full text
    All messenger RNAs (mRNAs) have a polyadenylic acid tail that is added during post transcriptional RNA processing. Investigation of the structure–function and interactions of polyadenylic acid is an important area to target for cancer and related diseases. Jatrorrhizine and coptisine are two important isoquinoline alkaloids that are structurally very similar, differing only in the substituents on the isoquinoline chromophore. Here we demonstrate that these alkaloids differentially induce a self-structure in single stranded poly(A) using absorbance, thermal melting and differential scanning calorimetry experiments. Jatrorrhizine was found to be more effective than coptisine in binding to poly(A) from spectroscopy and calorimetry data. Molecular modeling results suggested the involvement of more H-bonds in the complexation of the former with poly(A). It appears that the presence of substituents on the alkaloid that can form H-bonding interactions with the adenine nucleotides may play a critical role in the binding and structural rearrangement of poly(A) into the self-structure. The atomic force microscopy data directly visualized the poly(A) self-structured network. We propose a plausible mechanism of the small molecule induced self-structure formation in poly(A). The results presented here may help in the design of effective poly(A) targeted molecules for therapeutic use

    104

    full texts

    2,058

    metadata records
    Updated in last 30 days.
    EPrints@IICB Welcomes! - EPrints@IICB
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇